C
Comp360
Analyzing
Extracting target signal
Comp360
Extracting target signal
Comp360
Arcmira media summary
Browse COMP360 reviews, demos & launch coverage — 4 indexed from Bloomberg Podcasts, updated Dec 2025.
Synthetic formulation of psilocybin developed by Compass Pathways.
Compass Pathways' fully synthetic formulation of psilocybin, with robust patent protection until 2038, being tested in phase three trials.
Synthetic psilocybin formulation developed by Compass Pathways.
Arcmira tracks 4 indexed media appearances or mentions for COMP360, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "New Hope for People Battling With Depression | Bloomberg Businessweek" with transcript-derived context and links when available.
COMP360 is connected to treatment-resistant depression, Psychedelic drug market, Psychedelic Therapy in Arcmira's media graph.
4
Mentions
25.8K
Views
The trendline is visible, but the dated evidence behind COMP360 is in the premium layer.
“Synthetic formulation of psilocybin developed by Compass Pathways.”
“Compass Pathways' fully synthetic formulation of psilocybin, with robust patent protection until 2038, being tested in phase three trials.”
“Synthetic psilocybin formulation developed by Compass Pathways.”